Tag: head and neck cancer

The Case for Mistletoe in the Treatment of Laryngeal Cancer

This 2014 case report details a 68-year-old patient with aggressive, non-resectable laryngeal carcinoma who achieved complete remission following mistletoe therapy after failing to respond to chemoradiotherapy and salvage laryngectomy. The patient received high-dose intratumoral applications of Viscum album extract (mistletoe), leading to full recovery and hospital discharge. The report underscores

Read More »

No difference in disease-free survival after oral cancer resection with close tumor margins in patients with and without postoperative radiotherapy

This 2018 retrospective cohort study analyzed outcomes in 418 patients with oral or oropharyngeal squamous cell carcinoma based on margin status post-resection: clear (>5 mm), close (1–5 mm), and positive (≤1 mm). The 5-year disease-free survival (DFS) for patients with clear and close margins was not significantly different (79.3% vs.

Read More »

The Effect of an Adjuvant Mistletoe Treatment Programme in Resected Head and Neck Cancer Patients: A Randomised Controlled Clinical Trial

​A randomized controlled trial involving 477 patients with resected head and neck squamous cell carcinoma assessed the efficacy of an adjuvant mistletoe extract treatment. The study found no significant improvement in disease-free survival, with a hazard ratio of 0.959 (95% CI 0.725–1.268), and no differences in immune response or quality

Read More »